Medicare Enrolled
Dr. Albert Belli, DO
Pulmonary Disease · Hammonton, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Belli from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Belli?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Belli
Dr. Albert Belli is a pulmonary disease specialist in Hammonton, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Belli performed 3,459 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Belli received a total of $4,708 from 28 pharmaceutical and/or device companies across 333 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Belli is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 11% volume in NJ
$4,708 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,459
Medicare services
Top 11% in NJ for pulmonary disease
Not available
Unique patients (not deduplicated)
$86
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
703 | $99 | $185 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
426 | $65 | $175 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
321 | $145 | $360 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
320 | $97 | $225 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
313 | $139 | $325 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
226 | $23 | $106 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
218 | $30 | $97 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
218 | $31 | $97 |
| Prolonged inpatient or observation care, each additional 15 minutes This code is used for prolonged hospital inpatient or observation care services that extend beyond the total time required for the primary evaluation and management service. It covers each additional 15-minute increment of time spent by the provider. |
193 | $25 | $100 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
124 | $176 | $475 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
65 | $68 | $175 |
| Chest fluid aspiration with imaging guidance This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement. |
57 | $90 | $425 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
55 | $26 | $75 |
| New patient office visit, complex (60-74 min) | 52 | $173 | $388 |
| Exercise test for lung airway spasm A test performed during physical activity to check for spasms in the lung airways. |
42 | $66 | $185 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
42 | $108 | $195 |
| Home sleep test with portable monitor An unattended sleep study performed at home using a portable monitor that records breathing, heart rate, and oxygen levels. |
29 | $36 | $150 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $67 | $165 |
| Exercise stress test A test that monitors the heart and lungs while the patient exercises to evaluate their function under physical stress. |
13 | $56 | $160 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
13 | $101 | $266 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
12 | $72 | $400 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$4,708
Total received (2018-2024)
Avg $673/year across 7 years
Top 32% in NJ for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
333
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$577
2023
$398
2022
$802
2021
$610
2020
$655
2019
$1,053
2018
$613
Payments by company (2024)
GlaxoSmithKline, LLC.
$132
Actelion Pharmaceuticals US, Inc.
$104
GENZYME CORPORATION
$88
Regeneron Healthcare Solutions, Inc.
$66
AstraZeneca Pharmaceuticals LP
$46
Philips North America LLC
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
Mylan Specialty L.P.
$29
Inspire Medical Systems, Inc.
$18
Grifols USA, LLC
$16
Merck Sharp & Dohme LLC
$14
Top 3 companies account for 56.1% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$875
AstraZeneca Pharmaceuticals LP
$828
Actelion Pharmaceuticals US, Inc.
$462
Philips Electronics North America Corporation
$386
GENZYME CORPORATION
$264
Genentech USA, Inc.
$256
Regeneron Healthcare Solutions, Inc.
$227
Mylan Specialty L.P.
$211
United Therapeutics Corporation
$205
Insmed, Inc.
$198
Boehringer Ingelheim Pharmaceuticals, Inc.
$194
Bayer HealthCare Pharmaceuticals Inc.
$97
Gilead Sciences, Inc.
$93
Harmony Biosciences LLC
$71
Grifols USA, LLC
$55
Sunovion Pharmaceuticals Inc.
$39
Philips North America LLC
$35
Electromed, Inc.
$29
Merck Sharp & Dohme LLC
$28
Mallinckrodt Enterprises LLC
$26
Medtronic, Inc.
$23
Ethicon Inc.
$20
Inspire Medical Systems, Inc.
$18
CSL Behring
$16
Covidien LP
$15
Teva Pharmaceuticals USA, Inc.
$14
Janssen Pharmaceuticals, Inc
$13
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 46.0% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · ASMANEX · Adempas · Arikayce · BREO · BREZTRI · BREZTRI AEROSPHERE · DUPIXENT · Esbriet · FASENRA · INSPIRE · LONHALA MAGNAIR · Monarch Platform · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · ProAir Digihaler · Prolastin-C Liquid · REMODULIN · SMARTVEST · STIOLTO RESPIMAT · SYMBICORT · SuperDimension · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · Trilogy 100 · UPTRAVI · Veklury · WINREVAIR · Wakix · Wellcentive Undiv · XARELTO · Xolair · YUPELRI · Yupelri · ZERBAXA · Zemaira · inCourage · superDimension
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Pulmonary diseases in nearby ZIP areas
56
County median income
$76,819
Nearest hospital to ZIP centroid (approximate)
ANCORA PSYCH HOSP
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Belli is a clinical cardiology specialist, with above-average Medicare volume (top 11% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Belli experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Belli performed 703 hospital follow-up visit, high complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Belli receive payments from pharmaceutical companies?
Yes. Dr. Belli received a total of $4,708 from 28 companies across 333 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Belli's costs compare to other pulmonary diseases in Hammonton?
Dr. Belli's average Medicare payment per service is $86. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Belli) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Hammonton
Browse pulmonary diseases in Hammonton ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NJ
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NJ
Which NJ pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Actelion Pharmaceuticals US, Inc. Payments to Doctors
See all physicians who received payments from Actelion Pharmaceuticals US, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology